Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
Open | $5.590 |
Close | $5.350 |
Volume / Avg. | 7.291K / 33.758K |
Day Range | 5.311 - 5.785 |
52 Wk Range | 2.780 - 8.847 |
Market Cap | $32.255M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.19% |
Days to Cover | 5.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aprea Therapeutics (NASDAQ: APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Aprea Therapeutics (NASDAQ: APRE) was reported by Wedbush on Wednesday, March 27, 2024. The analyst firm set a price target for 11.00 expecting APRE to rise to within 12 months (a possible 85.19% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $5.94 last updated April 12, 2024 at 5:47 PM EDT.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.